{"product_id":"seracare-seraseq-sma-male-matched-cfdna-0720-1115","title":"Seraseq® SMA Male Matched cfDNA","description":"\u003cp\u003eThe Seraseq® Antepartum and Postpartum SMA Male – Matched cfDNA reference materials are designed to support the development, validation, and performance monitoring of Next-Generation Sequencing (NGS) and other amplified nucleic acid-based methods used in Spinal Muscular Atrophy (SMA) screening via Non-Invasive Prenatal Testing (NIPT). \u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSeraseq® Antepartum SMA Male cfDNA\u003c\/strong\u003e (Cat# 0720-1115) \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cul\u003e\n\u003cli\u003eSourced from the \u003cstrong\u003eblood of a pregnant patient carrying a male fetus with confirmed SMA\u003c\/strong\u003e \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cul\u003e\n\u003cli\u003eDesigned to mimic real-world \u003cstrong\u003eSMA-High-Risk NIPT samples\u003c\/strong\u003e \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSeraseq® Postpartum SMA Male cfDNA\u003c\/strong\u003e (Cat# 0720-1129) \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cul\u003e\n\u003cli\u003eDerived from \u003cstrong\u003ethe same patient’s blood collected after birth\u003c\/strong\u003e \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cul\u003e\n\u003cli\u003eIdeal for \u003cstrong\u003efetal fraction limit of detection studies, assay calibration, and dilution-based sensitivity testing\u003c\/strong\u003e \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSupplied as purified cfDNA in 0.1X TE buffer, the Antepartum SMA Male cfDNA (cat# 0720-1115), can be used as a reference material in assay development, validation, verification, analysis and routine monitoring of test performance as well as troubleshooting and training. It can be either used as supplied or diluted using the matching Seraseq Postpartum SMA Male cfDNA (cat# 0720-1129), in order to custom fetal fraction levels and perform limit of detection (LoD) studies. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFEATURES AND BENEFITS\u003c\/strong\u003e \u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinically sourced:\u003c\/strong\u003e derived from naturally occurring cfDNA from a gestation diagnosed with SMA. \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eThe only reference material \u003cstrong\u003ecompatible with a broad range of NIPT methods\u003c\/strong\u003e, including SNP-based NIPT assays. \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eProprietary method \u003cstrong\u003epreserves native cfDNA characteristics\u003c\/strong\u003e such as size profile of ~170 bp, SNP content and natural maternal-fetal size difference. This ensures the material behaves like patient samples. \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eHigh-quality Quality Assured 3rd party control: \u003cstrong\u003elot-to-lot consistency\u003c\/strong\u003e with materials manufactured in GMP-compliant and ISO 13485-certified facilities under strict quality controls. \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eEasy to use \u0026amp; highly stable: supplied as purified cfDNA in 0.1X TE buffer with \u003cstrong\u003e4 years long shelf-life\u003c\/strong\u003e and which can be added during the library preparation step \u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eDocuments\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/www.seracare.com\/globalassets\/seracare-resources\/pi-0720-1115.1129-seraseq-ante-and-post-sma-male-matched-cfdna.pdf\" target=\"_blank\" rel=\"noopener\"\u003eSeraseq® Antepartum \u0026amp; Postpartum SMA Male – Matched cfDNA (Package Insert)\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/www.seracare.com\/globalassets\/seracare-resources\/nrl-seraseq-nipt-reference-materials.pdf\" target=\"_blank\" rel=\"noopener\"\u003eSeraseq NIPT Reference Materials Non-Requirement Letter (SDS Non-Requirement Letter)\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eOrdering Information\u003c\/h2\u003e\u003ctable\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eCat. no.\u003c\/th\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003eSize\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e0720-1115\u003c\/td\u003e\n\u003ctd\u003eSeraseq® Antepartum SMA Male Matched cfDNA\u003c\/td\u003e\n\u003ctd\u003e1 x 25 µL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e0720-1129\u003c\/td\u003e\n\u003ctd\u003eSeraseq® Postpartum SMA Male Matched cfDNA\u003c\/td\u003e\n\u003ctd\u003e1 x 25 µL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"SeraCare","offers":[{"title":"Antepartum","offer_id":46798515273807,"sku":"0720-1115","price":0.0,"currency_code":"ILS","in_stock":true},{"title":"Postpartum","offer_id":46798515306575,"sku":"0720-1129","price":0.0,"currency_code":"ILS","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0712\/0748\/5519\/files\/0720-1115.jpg?v=1789655989","url":"https:\/\/www.danyel.co.il\/products\/seracare-seraseq-sma-male-matched-cfdna-0720-1115","provider":"danyel biotech","version":"1.0","type":"link"}